Algorhythm Holdings, Inc.·4

Mar 31, 6:28 AM ET

Thorn Scott 4

Research Summary

AI-generated summary

Updated

Algorhythm (RIME) Director Thorn Scott Receives Equity Awards

What Happened
Thorn Scott, a director of Algorhythm Holdings, Inc. (RIME), was granted two equity awards on November 20, 2025: a restricted stock award (RSA) for 19,532 shares and a non‑qualified stock option (NQSO) covering 39,063 shares. Both grants are reported at $0.00 (typical for awards/grants) and are grants rather than purchases or sales.

Key Details

  • Transaction date: November 20, 2025. Form filed March 31, 2026 (filing appears late).
  • Reported price: $0.00 for both the RSA and the option (transaction code A = Award/Grant).
  • RSA: 19,532 shares (contingent right to receive shares).
  • NQSO: option to purchase 39,063 shares (derivative).
  • Vesting: both awards vest in equal quarterly installments over one year from the grant date (see footnotes F1–F3).
  • Shares owned after the transaction: not specified in the provided filing.
  • Timeliness: the Form 4 was filed well after the 2‑business‑day window (transactionTimeliness = L), reducing near‑term transparency.

Context
The RSA is a restricted stock grant that will convert into actual shares as it vests; the NQSO is a right to buy shares in the future as it vests — neither represents an immediate sale or exercise. Such director equity grants are common as compensation and do not by themselves indicate insider buying or selling intent.